retatrutide vs triple agonist — genuinely asking which matters more
Posting this because I searched for it and got nothing useful. Setup: 1.7mg, week 30, sulphur burps present but not ruining anything. I changed exactly one variable — dose escalation — and tracked it for 22 weeks. Result: a difference, but a small one, and well inside what I would call noise if someone else posted…
This is correct. Triple agonism is genuinely different.
This is correct.
Disagree on that part. 95.1% and 96.2% on the same vial is normal.
This is correct. Triple agonism is genuinely different.
retatrutide is not approved anywhere for human use, posts must not read as instructions
retatrutide is not approved anywhere for human use, posts must not read as instructions
Adding to this: TRIUMPH is doing more work than the comment implies.
That is net peptide content, not purity. Different number, different meaning.
phase 2 numbers are not maintenance numbers, cite the trial
retatrutide is not approved anywhere for human use, posts must not read as instructions
Counter-anecdote: opposite result, same dose. Which mostly tells us the variance is huge.
retatrutide is not approved anywhere for human use, posts must not read as instructions Counter-anecdote: opposite result, same dose.
Yes, exactly this, and it is the bit that took me 84 weeks to accept.
triple agonism is phase 2, do not generalise
Strongly agree. Heart rate escalation needs the actual data, not impressions.